Found: 10
Select item for more details and to access through your institution.
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
- Published in:
- Oncogene, 2008, v. 27, n. 29, p. 4096, doi. 10.1038/onc.2008.40
- By:
- Publication type:
- Article
Transcription of AML1 in hematopoietic subfractions of normal adults.
- Published in:
- Annals of Hematology, 2002, v. 81, n. 5, p. 254, doi. 10.1007/s00277-002-0453-8
- By:
- Publication type:
- Article
Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
- Published in:
- Annals of Hematology, 2002, v. 81, n. 2, p. 64, doi. 10.1007/s00277-002-0427-x
- By:
- Publication type:
- Article
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 4, p. 687, doi. 10.1038/leu.2010.32
- By:
- Publication type:
- Article
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 4, p. 708, doi. 10.1038/leu.2008.27
- By:
- Publication type:
- Article